China Independent Clinical Laboratory Industry Report, 2014-2017
  • Oct.2014
  • Hard Copy
  • USD $2,000
  • Pages:78
  • Single User License
    (PDF Unprintable)       
  • USD $1,850
  • Code: ZLC010
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,850
  • Hard Copy + Single User License
  • USD $2,200

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion, up as much as 70% yr-on-yr, yet only accounting for 2%-3% of the total revenue of medical diagnosis.

There are about 110 independent clinical laboratories in today’s China, but most of them are small sized. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene as the strong performers thereof hold a combined market share of roughly 70%.

Because of a high requirement on the samples within a shorter time limit for place, the industry has a certain service radius. Therefore, a national layout is essential to business development and customer acquisition and chain-orientation the key development mode, for enterprises. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene have by far 19, 15, 14 and 8 independent medical laboratories across the country.

KingMed Diagnostics as the largest independent clinical laboratory enterprise in China enjoys a market share of approximately 40%, receiving recognition from both College of American Pathologists (CAP) and ISO15189. In the first half of 2014 it posted revenue of RMB846 million, up 37% yr-on-yr. Equipped with detection platforms for tumor diseases, genetic diseases, blood diseases, etc., KingMed Diagnostics will give top priority to tumor, reproduction and microbiological testing in the future.

ADICON is the first independent medical laboratory in domestic trans-regional chain operation, with a market share as high as 15%-18%. In recent years, many of its subsidiaries have successively won ISO15189 and CAP certificates

As an industry leader in the business model of "service + agent", DIAN Diagnostics gets involved in independent clinical laboratory, judicial expertise, diagnostic products agency and other areas. Currently, the company boasts an 18% market share in the Chinese independent clinical laboratory industry, capable of carrying out more than 1,000 medical diagnostic services.

Moreover, related enterprises abroad have also been well aware of the growth potential in China’s independent clinical laboratory industry, and set foot in the Chinese market via cooperation with local companies.

In February 2012, Quest and KingMed Diagnostics entered into a strategic alliance and established the KingMed&Quest Diagnostics Alliance Laboratory. And the Tianbo Lab jointly set up bythe South Korea-based SK Group and Xi’an Tianlong Science & Technology Co.Ltd started business in July 2014.

第三方实验室 英文_副本.png

China Independent Clinical Laboratory Industry Report, 2014-2017 highlights the followings:
20120114.gifPolicy environment, international market, development status, competition pattern, etc. of China’s independent clinical laboratory industry;
20120114.gifUpstream and downstream markets of China’s independent clinical laboratory industry and their impacts;
20120114.gifOperation, independent clinical laboratory business, etc. of 13 relevant enterprises in China;
20120114.gifProspect for the development of China’s independent clinical laboratory industry in 2014-2017 and operation comparison between key players.

1. Overview of Independent Clinical Laboratory
1.1 Definition
1.2 Industry Chain

2. Overview of China Independent Clinical Laboratory Industry
2.1 Policy Environment
2.1.1 Access Policy
2.1.2 Industry Policy
2.2 International Market
2.2.1 Status Quo
2.2.2 Benchmarking Enterprises
2.3 Development Status
2.4 Competition Pattern

3. Upstream and Downstream Markets of China Independent Clinical Laboratory Industry
3.1 Upstream Market
3.1.1 Status Quo
3.1.2 Competition Pattern
3.2 Downstream Market
3.2.1 Independent Clinical Laboratory Market Sees Huge Capacity
3.2.2 Healthcare Reform Boosts the Rapid Development of Independent Clinical Laboratory Market
3.2.3 Demand Diversification Promotes the Upgrading of Independent Clinical Laboratory Industry
3.2.4 Healthcare Demand Growth Propels the Independent Clinical Laboratory Forward Faster

4. Key Players
4.1 KingMed Diagnostics
4.1.1 Profile
4.1.2 Independent Clinical Laboratory
4.1.3 Operation and Development
4.2.1 Profile
4.2.2 Independent Clinical Laboratory
4.2.3 Development
4.3 DIAN Diagnostics
4.3.1 Profile
4.3.2 Operation 
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D and Investment
4.3.6 Independent Clinical Laboratory
4.3.7 Supply and Sales
4.3.8 Forecast and Outlook
4.4 DAAN Gene
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D and Investment
4.4.6 Independent Clinical Laboratory
4.4.7 Supply and Sales
4.4.8 Forecast and Outlook
4.5 NYMPHAVN Biotechnology
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 R&D and Investment
4.5.6 Independent Clinical Laboratory
4.5.7 Forecast and Outlook
4.6 SurExam
4.6.1 Profile
4.6.2 Operation
4.6.3 Gross Margin
4.6.4 Independent Clinical Laboratory
4.6.5 Supply and Sales
4.6.6 Forecast and Outlook
4.7 Amoy Diagnostics
4.7.1 Profile
4.7.2 Independent Clinical Laboratory
4.8 CapitalBio
4.8.1 Profile
4.8.2 Independent Clinical Laboratory
4.9.1 Profile
4.9.2 Independent Clinical Laboratory
4.10 Kindstar Global
4.10.1 Profile
4.10.2 Independent Clinical Laboratory
4.11 Deyi Diagnostics
4.11.1 Profile
4.11.2 Independent Clinical Laboratory
4.12 IPE-Bio
4.12.1 Profile
4.12.2 Independent Clinical Laboratory

5. Forecast and Outlook
5.1 Industry Development
5.2 Operation Comparison between Enterprises
5.2.1 Revenue
5.2.2 Net Income
5.2.3 Net Profit Margin
5.2.4 Gross Margin
5.2.5 Independent Clinical Laboratory
Independent Clinical Laboratory Industry Chain
Comparison of Independent Clinical Laboratory Undertakers between China and USA
Policies Concerning Independent Clinical Laboratory Industry in China, 2010-2013
U.S. Independent Clinical Laboratory Market Share by Test Item
U.S. Clinical Laboratory Market Share by Demand Side
Revenue and Net Income of Quest, 2009-2014
Gross Margin of Quest, 2009-2014
Major M&A Events of Quest Diagnostics, 2006-2014
Revenue and Operating Income of LabCorp, 2010-2013
Revenue Breakdown of LabCorp by Business, 2010-2013
Major M&A Events of LabCorp, 2007-2013
Basic Characteristics and Market Share of Major Independent Clinical Laboratory Enterprises in China, 2014
Market Size of In Vitro Diagnostic Industry in China, 2009-2013
Market Structure of In Vitro Diagnostic Industry in China, 2013
Comparison of Diagnostic Instrument Varieties between Domestic and Foreign Enterprises
Competition Pattern of Diagnostic Reagent Industry in China
IVD Revenue and Market Share of Major Diagnostic Reagent Enterprises in China, 2013
Business Revenue and Inspection Revenue of Medical Institutions in China, 2012
Medical Services of Health Agencies in China, 2012-2013
Number of Medical Institutions in China, 2012-2013
Health Expenditure and % of GDP in China, 1980-2013
Per Capita Health Expenditure and YoY Growth in China, 2006-2013E
Revenue of KingMed Diagnostics, 2012-2014
Revenue and Net Income of DIAN Diagnostics, 2009-2014
Revenue Breakdown of DIAN Diagnostics by Product, 2009-2014
Revenue Structure of DIAN Diagnostics by Product, 2009-2014
Revenue Breakdown of DIAN Diagnostics by Region, 2009-2014
Gross Margin of DIAN Diagnostics, 2009-2014
R&D Costs and % of Total Revenue of DIAN Diagnostics, 2010-2014
DIAN Diagnostics’ Revenue from Independent Clinical Laboratory and YoY Growth, 2009-2014
Name List and Procurement of DIAN Diagnostics’ Top 5 Suppliers, H1 2014
Name List and Procurement of DIAN Diagnostics’ Top 5 Suppliers, 2013
Name List and Sales of DIAN Diagnostics’ Top 5 Clients, H1 2014
Name List and Sales of DIAN Diagnostics’ Top 5 Clients, 2013
Revenue and Net Income of DIAN Diagnostics, 2012-2017E
Revenue and Net Income of DAAN Gene, 2009-2014
Revenue Breakdown of DAAN Gene by Business, 2009-2014
Revenue Structure of DAAN Gene by Business, 2009-2014
Revenue Breakdown of DAAN Gene by Region, 2009-2014
Revenue Structure of DAAN Gene by Region, 2009-2014
Gross Margin of DAAN Gene, 2009-2014
Gross Margin of DAAN Gene by Business, 2009-2014
R&D Costs and % of Total Revenue of DAAN Gene, 2011-2014
Main Assets and Business of DAAN Gene
Industrial Chain Layout of DAAN Gene
Medical Resources of Sun Yat-Sen University
DAAN Gene’s Revenue from Independent Clinical Laboratory and YoY Growth, 2009-2014
Top 5 Clients of DAAN Gene, H1 2014
Top 5 Clients of DAAN Gene, 2013
Top 5 Suppliers of DAAN Gene, 2013
Top 5 Suppliers of DAAN Gene, 2012
Revenue and Net Income of DAAN Gene, 2012-2017E
Revenue and Net Income of NYMPHAVN Biotechnology, 2009-2014
Revenue Breakdown of NYMPHAVN Biotechnology by Product, 2009-2014
Revenue Structure of NYMPHAVN Biotechnology by Product, 2009-2014
Gross Margin of NYMPHAVN Biotechnology, 2009-2014
Gross Margin of NYMPHAVN Biotechnology by Product, 2009-2014
Revenue and Gross Margin of Independent Clinical Laboratory of NYMPHAVN Biotechnology, 2009-H1 2014
Revenue and Net Income of NYMPHAVN Biotechnology, 2012-2017E
Revenue and Net Income of SurExam, 2011-2014
Gross Margin of SurExam, 2011-2014
Name List and Revenue of SurExam’s Top 5 Clients, 2011-2013
Name List and Procurement of SurExam’s Top 5 Suppliers, 2011-2013
Revenue and Net Income of SurExam, 2012-2017E
Some Strategic Partners of ADINOVO
Major Events of Kindstar Global
Revenue of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
Net Income of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
Net Profit Margin of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
Gross Margin of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
Revenue from Independent Clinical Laboratory of Major Independent Clinical Laboratory Enterprises in China, 2009-2014

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号